☰

Christopher S. Esslinger - Publications

Affiliations: 
Neuroscience University of Montana, Missoula, MT 
Area:
Pharmacology, Organic Chemistry
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology. 49: 850-61. PMID 16183084 DOI: 10.1016/J.Neuropharm.2005.08.009  0.852
2005 Bridges RJ, Esslinger CS. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacology & Therapeutics. 107: 271-85. PMID 16112332 DOI: 10.1016/j.pharmthera.2005.01.002  0.512
2005 Esslinger CS, Cybulski KA, Rhoderick JF. Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorganic & Medicinal Chemistry. 13: 1111-8. PMID 15670919 DOI: 10.1016/j.bmc.2004.11.028  0.329
2002 Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM. Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport. Journal of Medicinal Chemistry. 45: 2260-76. PMID 12014964 DOI: 10.1021/Jm010261Z  0.512
1999 Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, Bridges RJ. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Molecular Pharmacology. 56: 1095-104. PMID 10570036  0.571
1999 Carrigan CN, Esslinger CS, Bartlett RD, Bridges RJ, Thompson CM. Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system. Bioorganic & Medicinal Chemistry Letters. 9: 2607-12. PMID 10498218 DOI: 10.1016/S0960-894X(99)00444-8  0.503
1998 Esslinger CS, Koch HP, Kavanaugh MP, Philips DP, Chamberlin AR, Thompson CM, Bridges RJ. Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate. Bioorganic & Medicinal Chemistry Letters. 8: 3101-6. PMID 9873684 DOI: 10.1016/S0960-894X(98)00560-5  0.521
1998 Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ. Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology. 37: 839-46. PMID 9776380 DOI: 10.1016/S0028-3908(98)00080-X  0.624
Show low-probability matches.